ClearPoint Neuro, Inc. (CLPT) Insider Trading Activity

NASDAQ$10.1782+0.47 (4.84%)
Market Cap
$311.25M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
483 of 849
Rank in Industry
62 of 107

CLPT Insider Trading Activity

CLPT Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$2,466,997
8
100

Related Transactions

FALLON LYNNETTE Cdirector
0
$0
1
$56,714
$-56,714
Richards Timothy T.director
0
$0
1
$65,901
$-65,901
Klein Matthew B.director
0
$0
1
$185,440
$-185,440
BURNETT JOSEPHCEO and President
0
$0
5
$2.16M
$-2.16M

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also …

Insider Activity of ClearPoint Neuro, Inc.

Over the last 12 months, insiders at ClearPoint Neuro, Inc. have bought $0 and sold $2.47M worth of ClearPoint Neuro, Inc. stock.

On average, over the past 5 years, insiders at ClearPoint Neuro, Inc. have bought $0 and sold $1.4M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 25,000 shares for transaction amount of $31,250 was made by BURNETT JOSEPH MICHAEL (President and CEO) on 2018‑09‑25.

List of Insider Buy and Sell Transactions, ClearPoint Neuro, Inc.

2026-06-29SaleBURNETT JOSEPHCEO and President
20,000
0.0665%
$19.38
$387,600
-26.35%
2026-06-17SaleBURNETT JOSEPHCEO and President
61,843
0.2183%
$17.79
$1.1M
-13.30%
2026-06-01SaleRichards Timothy T.director
5,415
0.0174%
$12.17
$65,901
+12.82%
2026-05-21SaleKlein Matthew B.director
16,000
0.0529%
$11.59
$185,440
+20.38%
2026-05-20SaleFALLON LYNNETTE Cdirector
5,091
0.0169%
$11.14
$56,714
+25.45%
2026-02-25SaleBURNETT JOSEPHCEO and President
19,951
0.0671%
$15.17
$302,657
-16.85%
2026-01-26SaleBURNETT JOSEPHCEO and President
2,943
0.0108%
$15.57
$45,823
-7.39%
2026-01-09SaleBURNETT JOSEPHCEO and President
20,000
0.076%
$16.12
$322,400
-10.59%
2025-10-10SaleBURNETT JOSEPHCEO and President
26,463
0.0962%
$26.98
$714,021
-46.69%
2025-06-10SaleRichards Timothy T.director
10,000
0.0354%
$13.28
$132,800
-8.50%
2025-06-09SaleBURNETT JOSEPHCEO and President
21,247
0.0751%
$13.29
$282,373
-8.64%
2025-06-03SaleFALLON LYNNETTE Cdirector
10,200
0.0358%
$12.57
$128,226
-3.95%
2022-08-15SaleBURNETT JOSEPH MICHAELCEO and President
18,867
0.0889%
$16.07
$303,193
-43.20%
2021-11-11SaleBURNETT JOSEPH MICHAELCEO and President
10,000
0.0495%
$16.88
$168,800
-36.25%
2021-09-21SaleBURNETT JOSEPH MICHAELCEO and President
9,637
0.0508%
$17.98
$173,273
-37.50%
2021-06-21SaleBURNETT JOSEPH MICHAELCEO and President
25,000
0.1361%
$18.57
$464,250
-37.48%
2018-09-25PurchaseBURNETT JOSEPH MICHAELPresident and CEO
25,000
0.0092%
$1.25
$31,250
+74.16%
2018-08-24PurchaseBURNETT JOSEPH MICHAELPresident and CEO
7,500
0.0035%
$1.58
$11,850
+87.01%
2018-08-22PurchaseBURNETT JOSEPH MICHAELPresident and CEO
4,637
0.0021%
$1.55
$7,187
+78.13%
2018-05-21PurchaseBURNETT JOSEPH MICHAELPresident and CEO
7,500
0.0052%
$2.39
$17,903
-12.50%
Total: 70
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
BURNETT JOSEPHCEO and President
116842
0.3645%
$1.13M411
+56.7%
Richards Timothy T.director
87198
0.272%
$846,692.5812
KOOB CHARLES Edirector
736931
2.299%
$7.16M10
PIETRANGELO MICHAELdirector
451296
1.4079%
$4.38M70
+2.54%
Malernee James K. Jr.director
290659
0.9068%
$2.82M20
<0.0001%
SPENCER JOHN N JRdirector
96582
0.3013%
$937,811.2250
<0.0001%
Grillo Francis PCHIEF EXECUTIVE OFFICER
44588
0.1391%
$432,949.4830
<0.0001%
Jenkins Kimble L.director
34638
0.1081%
$336,334.9810
<0.0001%
Sainz Mariadirector
32895
0.1026%
$319,410.4510
<0.0001%
Conway Bruce C.director
17500
0.0546%
$169,925.00250
<0.0001%
Rooke Andrew K.director
10000
0.0312%
$97,100.0040
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$9,837,727
35
7.68%
$94.71M
ClearPoint Neuro, Inc.
(CLPT)
$1,105,104
34
-11.40%
$311.25M
$20,867,362
27
-3.90%
$467.11M
$58,749,198
24
16.21%
$100.45M
$842,771
15
6.44%
$214.28M

CLPT Institutional Investors: Active Positions

Increased Positions56+44.8%3M+29.51%
Decreased Positions49-39.2%2M-16.23%
New Positions26New1MNew
Sold Out Positions14Sold Out1MSold Out
Total Postitions132+5.6%12M+13.29%

CLPT Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$26,120.006.21%1.86M+127,595+7.36%2025-09-30
Vanguard Group Inc$21,012.004.99%1.5M+22,517+1.53%2025-09-30
Geode Capital Management, Llc$9,209.002.19%656,397+31,597+5.06%2025-09-30
State Street Corp$6,772.001.61%482,650+149,269+44.77%2025-09-30
Ubs Group Ag$5,061.001.2%360,705+205,295+132.1%2025-09-30
Brown Advisory Inc$4,640.001.1%330,727-177-0.05%2025-09-30
Lane Generational Llc$4,376.001.04%311,885+53,458+20.69%2025-09-30
Two Sigma Investments, Lp$4,357.001.04%310,526+288,598+1,316.12%2025-09-30
Boone Capital Management Llc$3,983.000.95%283,912+283,912New2025-09-30
Cahill Wealth Management, Llc$3,442.000.82%245,347+925+0.38%2025-03-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.